Regulation of BAG-1 IRES-mediated translation following chemotoxic stress.
There are three major isoforms of BAG-1 in mammalian cells, termed BAG-1L (p50), BAG-1M (p46) and BAG-1S (p36) that function as pro-survival proteins and are associated with tumorigenesis and chemoresistance. Initiation of BAG-1 protein synthesis can occur by both cap-dependent and cap-independent mechanisms and it has been shown that synthesis of BAG-1S is dependent upon the presence of an internal ribosome entry segment (IRES) in the 5'-UTR of BAG-1 mRNA. We have shown previously that BAG-1 IRES-meditated initiation of translation requires two trans-acting factors poly (rC) binding protein 1 (PCBP1) and polypyrimidine tract binding protein (PTB) for function. The former protein allows BAG-1 IRES RNA to attain a structure that permits binding of the ribosome, while the latter protein appears to be involved in ribosome recruitment. Here, we show that the BAG-1 IRES maintains synthesis of BAG-1 protein following exposure of cells to the chemotoxic drug vincristine but not to cisplatin and that this is brought about, in part, by the relocalization of PTB and PCBP1 from the nucleus to the cytoplasm.
Dobbyn
H C
HC
School of Pharmacy, University of Nottingham, Nottingham, UK.
Hill
K
K
Hamilton
T L
TL
Spriggs
K A
KA
Pickering
B M
BM
Coldwell
M J
MJ
de Moor
C H
CH
Bushell
M
M
Willis
A E
AE
D002945:Cisplatin / Q000633:toxicity; D004268:DNA-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006367:HeLa Cells; D006801:Humans; D018384:Oxidative Stress / Q000187:drug effects; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D012270:Ribosomes / Q000187:drug effects / Q000235:genetics*; D014157:Transcription Factors / Q000096:biosynthesis* / Q000235:genetics*; D050257:Tubulin Modulators / Q000633:toxicity; D014750:Vincristine / Q000633:toxicity
C091732:BCL2-associated athanogene 1 protein; D004268:DNA-Binding Proteins; D012333:RNA, Messenger; D014157:Transcription Factors; D050257:Tubulin Modulators; D014750:Vincristine; D002945:Cisplatin
J Virol. 2002 Mar;76(5):2529-42
11836431
EMBO J. 1996 Nov 15;15(22):6205-12
8947043
Biochim Biophys Acta. 2003 Mar 17;1603(2):83-98
12618309
EMBO J. 1997 Jun 16;16(12):3587-98
9218800
EMBO J. 1997 Aug 15;16(16):4887-96
9305631
EMBO J. 1997 Sep 15;16(18):5483-90
9312007
Mol Cell Biol. 1998 Jun;18(6):3112-9
9584152
Oncogene. 1998 Jul 16;17(2):227-36
9674707
Oncogene. 1998 Aug 27;17(8):981-9
9747877
Mol Cell Biol. 1998 Nov;18(11):6238-44
9774640
EMBO J. 1998 Dec 1;17(23):6871-8
9843493
Biochem J. 1999 Sep 15;342 Pt 3:519-26
10477262
Mol Cell. 2006 Aug 4;23(3):401-12
16885029
J Clin Oncol. 1999 Jun;17(6):1710-9
10561207
Mol Cell Biol. 2000 Feb;20(4):1162-9
10648601
Mol Cell. 2000 Apr;5(4):597-605
10882096
Oncogene. 2000 Aug 24;19(36):4174-7
10962579
Oncogene. 2001 Jul 5;20(30):4095-100
11494137
Genes Dev. 2001 Aug 15;15(16):2083-93
11511540
Mol Biol Cell. 2001 Dec;12(12):3808-20
11739782
Mol Biol Cell. 2003 Jun;14(6):2425-35
12808040
Cancer Res. 2003 Jul 15;63(14):4150-7
12874020
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8776-81
12851456
J Biol Chem. 2004 Apr 2;279(14):13721-8
14739278
Mol Cell Biol. 2004 Jun;24(12):5595-605
15169918
Eur J Biochem. 1995 Jun 1;230(2):447-53
7607214
Eur J Biochem. 1996 Mar 15;236(3):747-71
8665893
Nucleic Acids Res. 2003 Jan 15;31(2):639-46
12527772